Stockscreener 앱 받기
27.81
0.14%
-0.04
시간 외 거래:
28.15
0.34
+1.22%
전일 마감가:
$27.85
열려 있는:
$27.67
하루 거래량:
776.20K
Relative Volume:
0.93
시가총액:
$1.61B
수익:
$868.45M
순이익/손실:
$158.69M
주가수익비율:
10.27
EPS:
2.7087
순현금흐름:
$328.64M
1주 성능:
+0.07%
1개월 성능:
-19.13%
6개월 성능:
-14.54%
1년 성능:
-19.16%
1일 변동 폭
$27.11
$28.16
1주일 범위
$27.11
$28.92
52주 변동 폭
$25.52
$40.87
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
27.81 | 1.61B | 868.45M | 158.69M | 328.64M | 2.7087 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-23 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2026-02-23 | 다운그레이드 | Truist | Buy → Hold |
| 2026-02-11 | 재개 | UBS | Neutral |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-12-17 | 개시 | H.C. Wainwright | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-10 | 개시 | UBS | Buy |
| 2024-06-21 | 개시 | Citigroup | Buy |
| 2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-20 | 개시 | BofA Securities | Neutral |
| 2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
| 2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-04 | 개시 | Raymond James | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-14 | 개시 | Goldman | Neutral |
| 2020-09-14 | 개시 | Jefferies | Buy |
| 2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
Are Options Investors Anticipating Significant Volatility in Harmony Biosciences Shares? - Bitget
Are Options Traders Betting on a Big Move in Harmony Biosciences Stock? - TradingView
(HRMY) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Bull Bear: Is Harmony Biosciences Holdings Inc impacted by rising ratesTrade Risk Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Harmony Biosciences to report Q4 and full-year 2025 results - MSN
Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline - MSN
FOMO Trade: Can Harmony Biosciences Holdings Inc reach all time highs this year2026 Sector Review & Momentum Based Trading Signals - baoquankhu1.vn
Can Harmony Biosciences Holdings Inc reach all time highs this year - baoquankhu1.vn
Harmony Biosciences Stock Offers a Rare Buying Opportunity - Barron's
Aug Spikes: Whats the profit margin of Harmony Biosciences Holdings Inc2026 Technicals & Fast Gain Swing Alerts - baoquankhu1.vn
Harmony Biosciences reports 2025 revenue growth, issues 2026 outlook - MSN
Deutsche Bank cuts PT on Harmony Biosciences Holdings (HRMY) to $30 from $31 - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update - MarketBeat
Zuckerman Investment Group LLC Invests $3.40 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. $HRMY Shares Sold by Nan Fung Group Holdings Ltd - MarketBeat
HRMY SEC FilingsHarmony Biosciences Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Valuation Update: Can Harmony Biosciences Holdings Inc reach all time highs this yearVolume Spike & Verified Stock Trade Ideas - baoquankhu1.vn
Harmony’s next-gen narcolepsy drug advances with surprising new results - MSN
H.C. Wainwright Remains Bullish on Harmony Biosciences Holdings (HRMY) - MSN
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates - MSN
Harmony Biosciences Reports 2025 Revenue Growth, Issues 2026 Outlook - MyChesCo
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) - MSN
HC Wainwright & Co. Maintains Harmony Biosciences Holdings (HRMY) Buy Recommendation - MSN
Harmony Biosciences Holdings, Inc. $HRMY Shares Acquired by American Century Companies Inc. - MarketBeat
Does Mixed Q4 Results and Reaffirmed WAKIX Guidance Change The Bull Case For Harmony Biosciences (HRMY)? - simplywall.st
Harmony Biosciences Holdings Inc (HRMY) Stock Price, Trades & News - GuruFocus
Harmony Biosciences Eyes Blockbuster Future After Record Year - TipRanks
HRMY Technical Analysis & Stock Price Forecast - Intellectia AI
Harmony Biosciences to Participate in Upcoming Investor Conferences - pharmiweb.com
Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook on Its Promising 45% Upside Potential - DirectorsTalk Interviews
HRMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HC Wainwright Issues Pessimistic Forecast for HRMY Earnings - MarketBeat
Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31 - Bitget
Harmony Biosciences (NASDAQ:HRMY) Downgraded by Wall Street Zen to Hold - MarketBeat
MSN - MSN
Harmony Biosciences Downgrades Put Wakix Patent Risks In Sharp Focus - Yahoo Finance
HC Wainwright Issues Negative Estimate for HRMY Earnings - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Zacks Research - MarketBeat
US applications for jobless aid rose modestly to 212,000 last week as layoffs remain at historically healthy levels - Bitget
Safe Bulkers, Inc. to Participate in the Dry Bulk Shipping Panel at the DNB Carnegie Energy & Shipping Conference in Oslo - Bitget
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments - Yahoo Finance
Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval - simplywall.st
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), CareDx (CDNA) and Sotera Health (SHC) - The Globe and Mail
20 Best Investments in 2026 - Insider Monkey
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
UBS Group Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $36.00 - MarketBeat
Harmony Biosciences (HRMY): UBS Lowers Price Target to $36 | HRM - GuruFocus
HC Wainwright Reiterates Buy Rating for HRMY with $55 Target | H - GuruFocus
Harmony Biosciences' (HRMY) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - Finviz
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up - Finviz
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):